• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

混合脂质以改变脂质纳米粒的电离状态,从而实现特定组织靶向。

Mixing lipids to manipulate the ionization status of lipid nanoparticles for specific tissue targeting.

机构信息

Laboratory for Molecular Design of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido, Japan,

出版信息

Int J Nanomedicine. 2018 Dec 10;13:8395-8410. doi: 10.2147/IJN.S188016. eCollection 2018.

DOI:10.2147/IJN.S188016
PMID:30587967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6294068/
Abstract

INTRODUCTION

The development of targeted drug delivery systems is a rapidly growing area in the field of nanomedicine.

METHODS

We report herein on optimizing the targeting efficiency of a lipid nanoparticle (LNP) by manipulating the acid dissociation constant () value of its membrane, which reflects its ionization status. Instead of changing the chemical structure of the lipids to achieve this, we used a mixture of two types of pH-sensitive cationic lipids that show different values in a single LNP. We mixed various ratios of YSK05 and YSK12-C4 lipids, which have values of 6.50 and 8.00, respectively, in one formulation (referred to as YSK05/12-LNP).

RESULTS

The of the YSK05/12-LNP was dependent not only on the molar ratio of each lipid but also on the individual contribution of each lipid to the final (the YSK12-C4 lipid showed a higher contribution). Furthermore, we succeeded in targeting and delivering short interfering RNA to liver sinusoidal endothelial cells using one of the YSK05/12-LNPs which showed an optimum value of 7.15 and an appropriate ionization status (~36% cationic charge) to permit the particles to be taken up by liver sinusoidal endothelial cells.

CONCLUSION

This strategy has the potential for preparing custom LNPs with endless varieties of structures and final values, and would have poten tial applications in drug delivery and ionic-based tissue targeting.

摘要

简介

靶向药物传递系统的发展是纳米医学领域中一个快速发展的领域。

方法

我们在此报告通过操纵其膜的酸离解常数(pKa)值来优化脂质纳米颗粒(LNP)的靶向效率,该值反映了其电离状态。我们没有通过改变脂质的化学结构来实现这一点,而是使用两种类型的 pH 敏感阳离子脂质的混合物,在单个 LNP 中显示出不同的 pKa 值。我们混合了各种比例的 YSK05 和 YSK12-C4 脂质,它们在一个配方中的 pKa 值分别为 6.50 和 8.00(称为 YSK05/12-LNP)。

结果

YSK05/12-LNP 的 pKa 值不仅取决于每种脂质的摩尔比,还取决于每种脂质对最终 pKa 值的单独贡献(YSK12-C4 脂质的贡献更高)。此外,我们成功地使用 YSK05/12-LNP 之一将短干扰 RNA 靶向并递送至肝窦内皮细胞,该 LNP 具有最佳的 pKa 值 7.15 和适当的电离状态(~36%的正电荷),允许颗粒被肝窦内皮细胞摄取。

结论

这种策略有可能制备具有各种结构和最终 pKa 值的定制 LNP,并有可能在药物传递和基于离子的组织靶向方面得到应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4305/6294068/b46fa22ddf26/ijn-13-8395Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4305/6294068/f3c5e4b54ac2/ijn-13-8395Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4305/6294068/808669e38edf/ijn-13-8395Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4305/6294068/4d2c23c9c88a/ijn-13-8395Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4305/6294068/bcbcce2ca4d4/ijn-13-8395Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4305/6294068/8f8900690a35/ijn-13-8395Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4305/6294068/565570b9240f/ijn-13-8395Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4305/6294068/f8953acb837c/ijn-13-8395Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4305/6294068/b46fa22ddf26/ijn-13-8395Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4305/6294068/f3c5e4b54ac2/ijn-13-8395Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4305/6294068/808669e38edf/ijn-13-8395Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4305/6294068/4d2c23c9c88a/ijn-13-8395Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4305/6294068/bcbcce2ca4d4/ijn-13-8395Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4305/6294068/8f8900690a35/ijn-13-8395Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4305/6294068/565570b9240f/ijn-13-8395Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4305/6294068/f8953acb837c/ijn-13-8395Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4305/6294068/b46fa22ddf26/ijn-13-8395Fig8.jpg

相似文献

1
Mixing lipids to manipulate the ionization status of lipid nanoparticles for specific tissue targeting.混合脂质以改变脂质纳米粒的电离状态,从而实现特定组织靶向。
Int J Nanomedicine. 2018 Dec 10;13:8395-8410. doi: 10.2147/IJN.S188016. eCollection 2018.
2
Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo.了解 pH 敏感阳离子脂质的构效关系有助于合理鉴定有前途的用于体内递送 siRNA 的脂质纳米粒。
J Control Release. 2019 Feb 10;295:140-152. doi: 10.1016/j.jconrel.2019.01.001. Epub 2019 Jan 2.
3
A Multifunctional Envelope-Type Nano Device Containing a pH-Sensitive Cationic Lipid for Efficient Delivery of Short Interfering RNA to Hepatocytes In Vivo.一种包含pH敏感阳离子脂质的多功能包膜型纳米装置,用于在体内将短干扰RNA高效递送至肝细胞。
Methods Mol Biol. 2016;1364:71-8. doi: 10.1007/978-1-4939-3112-5_7.
4
[Development of siRNA Delivery Targeting the Tumor Microenvironment with a New Functional Device].[利用新型功能装置开发靶向肿瘤微环境的小干扰RNA递送方法]
Yakugaku Zasshi. 2019;139(11):1357-1363. doi: 10.1248/yakushi.19-00150.
5
Relationship Between the Physicochemical Properties of Lipid Nanoparticles and the Quality of siRNA Delivery to Liver Cells.脂质纳米颗粒的物理化学性质与小干扰RNA(siRNA)向肝细胞递送质量之间的关系
Mol Ther. 2016 Apr;24(4):788-95. doi: 10.1038/mt.2015.222. Epub 2015 Dec 18.
6
Hydrophobic scaffolds of pH-sensitive cationic lipids contribute to miscibility with phospholipids and improve the efficiency of delivering short interfering RNA by small-sized lipid nanoparticles.具有 pH 敏感性的阳离子脂质的疏水支架有助于与磷脂混合,并通过小尺寸脂质纳米颗粒提高短干扰 RNA 的递送效率。
Acta Biomater. 2020 Jan 15;102:341-350. doi: 10.1016/j.actbio.2019.11.022. Epub 2019 Nov 13.
7
pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes.载有 siRNA 的脂质纳米粒的 pH 敏感性聚乙二醇化可改善其在肝细胞中的主动靶向和基因沉默活性。
J Control Release. 2017 Sep 28;262:239-246. doi: 10.1016/j.jconrel.2017.07.046. Epub 2017 Aug 1.
8
The Effect of Size and Charge of Lipid Nanoparticles Prepared by Microfluidic Mixing on Their Lymph Node Transitivity and Distribution.微流控混合法制备的脂质纳米粒子的大小和电荷对其淋巴结转移和分布的影响。
Mol Pharm. 2020 Mar 2;17(3):944-953. doi: 10.1021/acs.molpharmaceut.9b01182. Epub 2020 Feb 5.
9
Reducing the Cytotoxicity of Lipid Nanoparticles Associated with a Fusogenic Cationic Lipid in a Natural Killer Cell Line by Introducing a Polycation-Based siRNA Core.通过引入基于聚阳离子的 siRNA 核心降低与融合阳离子脂质相关的脂纳米颗粒在自然杀伤细胞系中的细胞毒性。
Mol Pharm. 2018 Jun 4;15(6):2142-2150. doi: 10.1021/acs.molpharmaceut.7b01166. Epub 2018 Apr 30.
10
Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA.带负电荷的 siRNA 的中和作用导致负载高水平 siRNA 的脂质纳米颗粒具有更好的安全性和高效的基因沉默活性。
J Control Release. 2018 Aug 28;284:179-187. doi: 10.1016/j.jconrel.2018.06.017. Epub 2018 Jun 21.

引用本文的文献

1
Prediction of the Apparent p Value of Lipid Nanoparticles by Density Functional Theory.基于密度泛函理论预测脂质纳米颗粒的表观p值
ACS Mater Au. 2025 Feb 27;5(3):451-457. doi: 10.1021/acsmaterialsau.4c00158. eCollection 2025 May 14.
2
Celery seed derived reconstituted lipid nanoparticles as an innate neuron-targeted neuroprotective nanomedicine for ischemic stroke treatment.芹菜籽衍生的重构脂质纳米颗粒作为一种用于缺血性中风治疗的天然神经元靶向神经保护纳米药物。
J Nanobiotechnology. 2025 Apr 17;23(1):298. doi: 10.1186/s12951-025-03372-4.
3
Tetrahydropyrimidine Ionizable Lipids for Efficient mRNA Delivery.

本文引用的文献

1
Protein corona: a new approach for nanomedicine design.蛋白质冠层:纳米医学设计的新方法。
Int J Nanomedicine. 2017 Apr 18;12:3137-3151. doi: 10.2147/IJN.S129300. eCollection 2017.
2
Design of Ionizable Lipids To Overcome the Limiting Step of Endosomal Escape: Application in the Intracellular Delivery of mRNA, DNA, and siRNA.可离子化脂质的设计以克服内涵体逃逸的限制步骤:在 mRNA、DNA 和 siRNA 的细胞内递送上的应用。
J Med Chem. 2016 Apr 14;59(7):3046-62. doi: 10.1021/acs.jmedchem.5b01679. Epub 2016 Mar 17.
3
A lipid nanoparticle for the efficient delivery of siRNA to dendritic cells.
可离子化的四氢嘧啶脂质用于高效 mRNA 递送。
ACS Nano. 2024 Oct 22;18(42):29045-29058. doi: 10.1021/acsnano.4c10154. Epub 2024 Oct 11.
4
Decoding trends in mRNA vaccine research: A comprehensive bibliometric study.解码 mRNA 疫苗研究趋势:一项全面的文献计量学研究。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2355037. doi: 10.1080/21645515.2024.2355037. Epub 2024 May 30.
5
Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach.采用实验设计方法对用于胎盘mRNA递送的可电离脂质纳米颗粒进行系统开发。
Bioact Mater. 2023 Dec 22;34:125-137. doi: 10.1016/j.bioactmat.2023.11.014. eCollection 2024 Apr.
6
'Passive' nanoparticles for organ-selective systemic delivery: design, mechanism and perspective.用于器官选择性全身递送的“被动”纳米颗粒:设计、机制和展望。
Chem Soc Rev. 2023 Oct 30;52(21):7579-7601. doi: 10.1039/d2cs00998f.
7
Delivery of gene editing therapeutics.基因编辑治疗药物的递送。
Nanomedicine. 2023 Nov;54:102711. doi: 10.1016/j.nano.2023.102711. Epub 2023 Oct 7.
8
Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs.用于递送基因药物的被动、主动和内源性器官靶向脂质及聚合物纳米颗粒。
Nat Rev Mater. 2023;8(4):282-300. doi: 10.1038/s41578-022-00529-7. Epub 2023 Jan 19.
9
mRNA-Loaded Lipid Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy.靶向树突状细胞的mRNA负载脂质纳米颗粒用于癌症免疫治疗
Pharmaceutics. 2022 Jul 28;14(8):1572. doi: 10.3390/pharmaceutics14081572.
10
The Future of Tissue-Targeted Lipid Nanoparticle-Mediated Nucleic Acid Delivery.组织靶向脂质纳米颗粒介导的核酸递送的未来
Pharmaceuticals (Basel). 2022 Jul 20;15(7):897. doi: 10.3390/ph15070897.
一种用于将小干扰RNA高效递送至树突状细胞的脂质纳米颗粒。
J Control Release. 2016 Mar 10;225:183-91. doi: 10.1016/j.jconrel.2016.01.042. Epub 2016 Jan 26.
4
Relationship Between the Physicochemical Properties of Lipid Nanoparticles and the Quality of siRNA Delivery to Liver Cells.脂质纳米颗粒的物理化学性质与小干扰RNA(siRNA)向肝细胞递送质量之间的关系
Mol Ther. 2016 Apr;24(4):788-95. doi: 10.1038/mt.2015.222. Epub 2015 Dec 18.
5
Bridging small interfering RNA with giant therapeutic outcomes using nanometric liposomes.利用纳米脂质体将小干扰 RNA 与巨大的治疗效果联系起来。
J Control Release. 2015 Dec 28;220(Pt A):368-387. doi: 10.1016/j.jconrel.2015.10.050. Epub 2015 Oct 31.
6
Novel pH-sensitive multifunctional envelope-type nanodevice for siRNA-based treatments for chronic HBV infection.新型 pH 敏感多功能包膜型纳米装置,用于基于 siRNA 的慢性乙型肝炎病毒感染治疗。
J Hepatol. 2016 Mar;64(3):547-55. doi: 10.1016/j.jhep.2015.10.014. Epub 2015 Oct 24.
7
Size-dependent specific targeting and efficient gene silencing in peritoneal macrophages using a pH-sensitive cationic liposomal siRNA carrier.采用 pH 敏感阳离子脂质体 siRNA 载体实现对腹腔巨噬细胞的尺寸依赖性特异性靶向和高效基因沉默。
Int J Pharm. 2015 Nov 10;495(1):171-178. doi: 10.1016/j.ijpharm.2015.08.044. Epub 2015 Sep 7.
8
Lipid nanoparticle delivery systems for siRNA-based therapeutics.基于 siRNA 的治疗的脂质纳米颗粒递药系统。
Drug Deliv Transl Res. 2014 Feb;4(1):74-83. doi: 10.1007/s13346-013-0161-z.
9
Lipid nanoparticles for short interfering RNA delivery.用于短干扰RNA递送的脂质纳米颗粒。
Adv Genet. 2014;88:71-110. doi: 10.1016/B978-0-12-800148-6.00004-3.
10
Ionizable amphiphilic dendrimer-based nanomaterials with alkyl-chain-substituted amines for tunable siRNA delivery to the liver endothelium in vivo.基于可电离两亲性树枝状大分子的纳米材料,其带有烷基链取代胺,用于在体内将小干扰RNA可调谐地递送至肝内皮细胞。
Angew Chem Int Ed Engl. 2014 Dec 22;53(52):14397-401. doi: 10.1002/anie.201408221. Epub 2014 Oct 29.